Biomimedica

Pioneering New Approaches to Cartilage Replacement

Biomimedica is a medical device company that is pioneering new approaches to joint repair through its proprietary, synthetic cartilage technology.

Osteoarthritis (OA) is a degenerative disease of articular cartilage that affects nearly 27 million Americans. Articular cartilage serves as the bearing surface for all moving joints in the human body. As a result of a number of factors (including age, developmental abnormality, trauma and genetic predisposition), the articular cartilage in a joint becomes thinner over time and can develop focal or large lesions. These lesions are painful and initiate a reactive response in the subchondral bone that leads to the formation of bone spurs, or osteophytes, which cause additional pain in the joint. OA patients experience increasingly frequent and progressively more severe pain upon weight bearing and upon movement that can severely restrict activity and reduce quality of life.

Biomimedica is developing earlier intervention solutions to treat osteoarthritis that will allow patients to maintain a pain-free, active lifestyle.